PSC RESEARCH LIBRARY / 2026
Follow the evidence.
Not the hype.
Start with molecular identity, move through experimental design, and check the strongest available source before drawing a conclusion. Every guide below links out to an authoritative record or peer-reviewed reference.
01
Find the concept. Search by topic, method, or database.
02
Check the evidence stage. Molecular, cell, animal, human, and approved are different claims.
03
Open the source. Read the actual record, methods, limitations, and date.
KNOWLEDGE MODULES / 01
Search the field guide.
These concise explainers teach how to investigate a peptide or research-compound question. They do not provide product-specific efficacy, safety, dosing, or administration advice.
No guide matches that search.Try a broader term or choose “All.”
EVIDENCE MAP / 02
One result is not every result.
A claim should say what was studied, in which model, against what comparison, and with which endpoint. Evidence at one stage does not automatically establish the next.
- 01MOLECULAR
Identity & properties
Sequence, mass, structure, chemical form, and analytical method.
- 02IN VITRO
Cells & assays
A controlled cell-free or cell/tissue system outside an intact organism; material may be human- or non-human-derived.
- 03IN VIVO
Animal models
Organism-level observations that may or may not translate to people.
- 04CLINICAL
Human studies
Populations, comparators, outcomes, results, and—where applicable—registered protocols.
- 05REGULATORY
Reviewed status
Approval is indication- and jurisdiction-specific; verify in the live database.
A higher step is not automatically a better experiment. It answers a different kind of question. The critical test is whether the evidence supports the exact claim being made.
RESEARCH RECORD CHECK / 03
Six questions before you trust a summary.
Use this checklist on papers, database records, product descriptions, social posts, and AI-generated explanations.
NIH rigor & reproducibility guidance ↗What is the exact material?
Name, sequence or structure, chemical form, and source should be unambiguous.
What model was studied?
Cell-free assay, cell line, animal model, or human participants are not interchangeable.
What was the comparator?
Look for negative and positive controls, randomization, and blinding where appropriate.
What endpoint was measured?
A surrogate laboratory signal is different from a clinical outcome.
How precise is the estimate?
Sample size, uncertainty, effect size, missing data, and multiple comparisons matter.
Can the result be checked?
Methods, identifiers, protocol history, data availability, and independent replication strengthen traceability.
CATALOG RESEARCH MAP / 04
Start with the public record.
Each catalog entry opens neutral searches in PubMed, PubChem, and ClinicalTrials.gov. Search results are discovery tools—not proof of identity, quality, safety, efficacy, or approval.
EDITORIAL STANDARD / 05
How PSC builds this library.
Source before summary
Official databases, regulator records, scholarly articles, and established scientific references are favored over supplier or influencer claims.
Evidence stage named
Laboratory, animal, human, and regulatory findings are kept distinct. “Studied” never means “approved.”
No invented certainty
Unknowns, model limitations, conflicting results, and missing human evidence are part of the answer—not fine print.
Commercial separation
Catalog availability does not determine scientific evidence. Educational summaries do not establish a product-specific use.
Educational content only. No dosing, administration, diagnostic, medical, veterinary, or patient-specific guidance is provided. Database records and regulatory status can change; confirm time-sensitive facts in the linked live source.